Intestinal stem cells (ISCs) are maintained by a niche mechanism, in which multiple ISCs undergo differential fates where a single ISC clone ultimately occupies the niche. Importantly, mutations continually accumulate within ISCs creating a potential competitive niche environment. Here we use single cell lineage tracing following stochastic transforming growth factor β receptor 2 (TgfβR2) mutation to show cell autonomous effects of TgfβR2 loss on ISC clonal dynamics and differentiation. Specifically, TgfβR2 mutation in ISCs increased clone survival while lengthening times to monoclonality, suggesting that Tgfβ signaling controls both ISC clone extinction and expansion, independent of proliferation. In addition, TgfβR2 loss in vivo reduced crypt fission, irradiation-induced crypt regeneration, and differentiation toward Paneth cells. Finally, altered Tgfβ signaling in cultured mouse and human enteroids supports further the in vivo data and reveals a critical role for Tgfβ signaling in generating precursor secretory cells. Overall, our data reveal a key role for Tgfβ signaling in regulating ISCs clonal dynamics and differentiation, with implications for cancer, tissue regeneration, and inflammation.
Intestinal stem cells (ISCs) are maintained by a niche mechanism, in which multiple ISCs undergo differential fates where a single ISC clone ultimately occupies the niche. Importantly, mutations continually accumulate within ISCs creating a potential competitive niche environment. Here we use single cell lineage tracing following stochastic transforming growth factor β receptor 2 (TgfβR2) mutation to show cell autonomous effects of TgfβR2 loss on ISC clonal dynamics and differentiation. Specifically, TgfβR2 mutation in ISCs increased clone survival while lengthening times to monoclonality, suggesting that Tgfβ signaling controls both ISC clone extinction and expansion, independent of proliferation. In addition, TgfβR2 loss in vivo reduced crypt fission, irradiation-induced crypt regeneration, and differentiation toward Paneth cells. Finally, altered Tgfβ signaling in cultured mouse and human enteroids supports further the in vivo data and reveals a critical role for Tgfβ signaling in generating precursor secretory cells. Overall, our data reveal a key role for Tgfβ signaling in regulating ISCs clonal dynamics and differentiation, with implications for cancer, tissue regeneration, and inflammation.
intestinal stem cell | Tgfβ | lgr5 | TgfβR2 | Paneth cell T he intestinal epithelium is constantly renewed by proliferating, multipotent, and self-renewing intestinal stem cells (ISCs) (1) . There are two main populations of ISCs: (i) a proliferating ISC population that is important for homeostasis of the niche residing below the +4 position and expressing a set of markers [e.g., leucine-rich repeat-containing G-protein coupled receptor 5 (Lgr5) and Olfm4] and (ii) a quiescent ISC population residing near the +4 position and expressing a different set of markers (e.g., Bmi1 and Hopx) (2) . Proliferating ISCs are the workhorses during normal homeostasis and are maintained within the niche by a close relationship with Paneth cells (3) and the stroma (4) . The proliferating ISC population can be further divided into a smaller number (4-8) of functional ISCs (5, 6) , which are located at the bottom of the crypt and are biased toward survival within the niche (7) . The proliferating ISCs use a population niche mechanism called neutral drift that combines differential ISC clone fates (8, 9) . In neutral drift, a constant number of proliferative ISCs are maintained by a balance of ISC clone extinction with ISC clone expansion. Thus, the ISC niche must have signaling mechanisms that maintain and balance the different states of ISCs.
Much is known about the effects of WNT, BMP, and Notch signaling within the ISC niche (10) , whereas little is known about the role that Tgfβ signaling through transforming growth factor β receptor 2 (TgfβR2) has on the ISC niche. Tgfβ signaling is known to play important roles in differentiation, cell motility, cell cycle, apoptosis, and inflammation (11) , is critical during several phases of mammalian development (12) (13) (14) , and is altered in cancer (15, 16) . Tgfβ signaling involves Tgfβ ligands (Tgfβ1, 2, or 3) that bind to and activate Tgfβ receptors on the cell surface. The receptors, TgfβR1 and TgfβR2, form a heterodimer on ligand binding to create an active complex. The activated Tgfβ receptor complex phosphorylates and activates Smad2 and Smad3 (pSmad2/3), which in turn bind to Smad4, forming a transcriptional complex, which translocates to the nucleus and regulates target genes. Given the basic role of Tgfβ signaling within a cell, it seems likely that Tgfβ signaling will play a role within ISCs.
Previous investigations of TgfβR2 mutation in the intestine using epithelium-wide deletion did not detect any obvious phenotypes (17) (18) (19) . However, the design of these studies would not have detected phenotypes resulting from competition between Tgfβ-positive and -negative cells within the crypt. For example, there is evidence from the hematopoietic system that competition between cells with and without Tgfβ signaling resulted in a different phenotype compared with an environment with no competition (20) . ISCs are constantly dividing and therefore continually accumulating diverse mutations, which can potentially result in competition-driven drift between ISCs. Recent studies have demonstrated that isolated single ISCs with mutations in Kras and Apc are more prone to clonal expansion relative to surrounding WT ISCs (21, 22) . Here we examine the effects of stochastic loss of TgfβR2 on competition between mutant and WT ISCs.
Results

Continuous and Pulse Labeling of ISCs Reveal Altered Clonal Dynamics
Following TgfβR2 Mutation. We used the stochastic Pms2 cre system to determine the consequences of sporadic, low-frequency,
Significance
Although Tgfβ signaling is important in intestinal development and cancer, little is known about the consequences of sporadic transforming growth factor β receptor 2 (TgfβR2) mutation in intestinal stem cells (ISCs). By labeling single, TgfβR2-mutant ISCs, we measured the effects of TgfβR2 loss on competitiondriven clonal dynamics and differentiation. Specifically, we found that stochastic loss of TgfβR2 increases clonal survival while paradoxically decreasing clonal expansion and crypt fission, further elucidating mechanisms responsible for the role of Tgfβ signaling in ISCs on tumor initiation and tissue regeneration. In addition, we found that Tgfβ signaling modulates the generation of secretory cell precursors, revealing a role for Tgfβ signaling in altering ISC differentiation with implications for cancer, tissue regeneration, and inflammation.
single cell TgfβR2 disruption in isolated crypts within the mouse small intestine (23) (24) (25) . In our system, the Pms2 cre allele is comprised of a revertible out-of-frame cre gene that is targeted to Pms2, a DNA mismatch repair gene expressed in multiple cell types, including ISCs. By using a stochastic process (spontaneous frame-shift mutation), activation of Cre recombinase occurs at a defined rate resulting in continuous labeling similar to another system (5) (Fig.  S1A ). Lineage labeling in the intestine will only be retained when Cre activation occurs in a long-lived progenitor cell (i.e., stem cell), thus making the Pms2 cre mouse system ideal for continuous clonal labeling (Fig. 1A) . When this system is combined with conditional TgfβR2 alleles (TgfβR2 fx ), we can monitor the fate of isolated ISCs in a niche with neutral drift (i.e., labeled WT ISC surrounded by unlabeled, WT ISCs) or in a niche with competition-driven drift (i.e., labeled TgfβR2-mutant ISC surrounded by unlabeled, WT ISCs).
Using the stochastic system described above, we compared proximal small intestines of Pms2 ; R26R (TgfβR2 mutant) mice. First, we determined the number of partial and fully labeled β-gal + crypts at different ages. For simplicity, we divided the crypt into onequarter fractions or clone sizes (Fig. 1B) . For WT mice, we found a constant number of partially labeled crypts with age (average, 217 β-gal + foci) ( Fig. 1D ) and, as expected, an increasing number of fully labeled crypts with age (∼4.1 β-gal + foci/d) (Fig. 1C) . Interestingly, for TgfβR2-mutant mice, we found greater numbers of both partially labeled (average, 630 β-gal + foci; P < 0.001 for intercept) (Fig. 1D ) and fully labeled crypts (∼8.3 β-gal + foci/d; P = 0.001 for slope) compared with WT mice (Fig. 1C) . The altered drift following TgfβR2 loss in ISCs was independent of cell proliferation, apoptosis, or the total cell number within the crypt (Fig. S2 A-C) . In addition, Tgfβ-responsive cells, as measured by pSmad2/3 staining, were evenly distributed throughout the crypt bottom (Fig. S2D) . These results are consistent with TgfβR2-mutant ISCs having greater competition-driven clonal survival (more fully labeled crypts with age) while also having an elongated time to full crypt occupancy (more partially labeled crypts) compared with labeled, WT ISCs. We verified Cre-mediated recombination of the TgfβR2 floxed allele by PCR assay on microdissected crypts and found that 92% (23/25) of β-gal + foci were positive for TgfβR2 recombination, whereas only 10% (1/10) of β-gal neg foci were positive for TgfβR2 recombination (P < 0.001; Fig. S3A ). The PCR data strongly support efficient recombination of TgfβR2 in β-gal + cells and the stochastic nature of the Pms2 cre system with a calculated β-gal + activation rate of 0.0003 β-gal + events per cell (Fig. S3C ), making multiple, independent TgfβR2 mutations in a single crypt highly unlikely. In addition, we found pSmad2/3 + cells in 15% (151/1,028) of β-gal neg crypts, but only in 4% (15/404) of β-gal + crypts from TgfβR2 fx/fx mice, supporting loss of Tgfβ signaling in 75% [1 − (observed/expected)] of β-gal + crypts. Therefore, the data for β-gal + cells in the TgfβR2-mutant mice are representative of a single TgfβR2 mutant ISC arising within a crypt of WT ISCs.
To determine independently the consequences of eliminating Tgfβ signaling in proliferating ISCs, we used Lgr5-CreER mice with, or without, conditional TgfβR2 alleles. The Lgr5-CreER mouse contains Cre fused to the estrogen receptor and is expressed from the ISC-specific promoter, Lgr5 (26). Thus, after injection of tamoxifen (pulse labeling), Cre becomes active in ISCs and, when combined with a LacZ reporter allele (R26R), can label the ISC for lineage tracing ( Fig. 2A) . By labeling a small number of ISCs in any given crypt, we can follow the progression of a crypt from partially labeled to fully labeled (time to monoclonality) and the fraction of surviving β-gal + crypts (crypt succession) (Fig. S1B ). To study drift, we compared the clone size distribution or crypt succession with time in Lgr5-CreER; TgfβR2 +/+ ; R26R (WT) and Lgr5-CreER; TgfβR2 fx/fx ; R26R (TgfβR2-mutant) mice, injected with tamoxifen at 2 mo of age. By using a single dose of tamoxifen (2 mg/mouse), we were able to induce mosaic recombination in a fraction of crypts (∼20%) while still obtaining recombination of the TgfβR2 fx alleles (Fig. S3A ). The dose of tamoxifen used can result in multiple, recombination events per crypt (Fig. S3B) ; therefore, it is possible to have β-gal neg and β-gal + ; TgfβR2-mutant ISCs within a single crypt. For pulse labeling, clonal survival was increased in TgfβR2-mutant crypts compared with WT crypts (Fig. 2B) (P = 0.02 for log-transformed slope). In addition, the time to monoclonality was elongated in TgfβR2-mutant crypts compared with WT crypts ( ) ISCs. Our model has the following parameters: N (number of stem cells), m (mutation rate), time, λ (WT replacement rate), TgfβR2-λ (TgfβR2 −/− replacement rate), and F R (TgfβR2 −/− replacement factor) (Fig. S4A) . Our model is independent of cell proliferation; however, TgfβR2 loss did not have any appreciable effect on proliferation in cells located at the crypt base (Fig. S2A) . Simplistically, the fate of an isolated single ISC depends on the relative balance between clone extinction vs. clone expansion, where λ reflects the rate of ISC clone extinction, whereas F R reflects the rate of competitive ISC clone expansion. First, we calculated N and λ for WT crypts using our computational model with both the continuous and pulse labeling, which revealed that the best fit for WT crypts was N = 4 and λ = 0.14-0.15 (Table S1 and Fig. S5 A and C), similar to a previous estimate (5) . Next, we calculated the effects of TgfβR2 mutation on ISC competition-driven drift. These simulations revealed an approximately sevenfold decreased clone extinction (TgfβR2-λ) and an approximately threefold decreased competitive clone expansion (F R ) (Fig. S4 B and C and Table S1 ). These simulations indicate an approximately twofold greater reduction in ISC clone extinction compared with clone expansion following loss of TgfβR2 when in competition with WT ISCs, leading to the slower but overall increased niche occupancy. The net result is that TgfβR2-mutant ISCs have increased clone survival compared with WT ISCs. Because ISC proliferation is not altered with TgfβR2 mutation, these results suggest that the increased clone survival of TgfβR2-mutant ISCs is through altered differentiation. Our data revealed that loss of TgfβR2 could lengthen times to monoclonality, supporting reduced ISC clone expansion. Next, we examined the effects of stochastic mutation on crypt fission, the process by which a single crypt splits into two crypts presumably caused by an increased number of ISCs (i.e., ISC clone expansion). The stochastic nature of the Pms2 cre system make multiple, independent TgfβR2 mutations in neighboring crypts highly unlikely; thus, the distribution of crypt patch sizes reflects crypt fission events over time. Therefore, we determined the numbers of β-gal Fig. 3A) . These results are consistent with decreased crypt fission following stochastic TgfβR2 mutation.
Next, we combined the Villin-Cre allele with conditional TgfβR2 fx alleles (TgfβR2 IEKO ) (17, 19, 27) to determine whether the effects of TgfβR2 loss on crypt fission were caused by competition with WT cells or by TgfβR2-mutant crypts inherently having a reduced level of crypt fission. The TgfβR2 IEKO mice exhibit loss of TgfβR2 throughout the intestinal epithelium; thus, almost all epithelial cells (and crypts) become TgfβR2 −/− without intra-or intercrypt competition. Previous reports on these mice did not report any obvious differences from the intestines of WT mice; however, there was not a close examination of crypt fission rates (17, 19, 27) . Therefore, we examined the number of crypts undergoing fission (crypts in the process of budding) in adult TgfβR2 IEKO (mean, 16 mo) or WT (mean, 15.4 mo) mice (P = 0.76). Interestingly, we found a reduced percentage of crypts undergoing fission in TgfβR2
IEKO intestine compared with WT intestine (Fig. 3B) . These results revealed that TgfβR2-mutant crypts inherently have reduced crypt fission whether in competition with neighboring crypts or not. (28), and intestine-wide loss of TgfβR2 resulted in a slower rate of crypt regeneration following irradiation (27) . Therefore, we studied the effects of irradiation (12 Gy) on TgfβR2-mutant ISCs when competing with WT ISCs using the pulse labeling model (Lgr5-CreER mice). We define β-gal + foci that extend from the crypt onto the body of the villus as a "repopulated clone" and β-gal + foci that were only present on the body of the villus (not extending into the crypt) as an "extinguished clone." Mice were given a single pulse of tamoxifen and then 3 wk later were exposed to 12 Gy of irradiation. Five to 7 d after irradiation, TgfβR2-mutant cell lineages in the proximal small intestine were scored as repopulated clones in only 35% of crypts compared with 66% in WT cell lineages (Fig.  3C) . Finally, we found that irradiation altered the distribution of pSmad2/3 + cells toward the crypt base (Fig. S2D) and dramatically increased the pSmad2/3 staining intensity and number (∼20-fold) of pSmad2/3 + cells within the crypt, specifically in the Paneth cell lineage (Fig. 3D) . However, there was minimal change in the number of pSmad2/3 + cells in the stroma after irradiation (Fig.  3D) . These data support a key role for Tgfβ signaling through TgfβR2 within the ISC population in crypt regeneration after damage and a role for Tgfβ signaling in the Paneth cell lineage.
Loss of
TgfβR2 in ISCs in Vivo Reduces the Chance of Regeneration Following Irradiation. Next, we studied the effects of irradiation following sporadic loss of TgfβR2 in ISCs because ISC clonal expansion is necessary following crypt damage, and our data suggest that TgfβR2 loss retards ISC clonal expansion. A subset of Lgr5 + ISCs is necessary for crypt regeneration following irradiation
Cell Type Analysis in Vivo Reveals a Role for TgfβR2 in the Generation
of Paneth Cells. Because our data suggested a role for Tgfβ signaling in differentiation, we examined Pms2 cre mice for altered cell labeling after TgfβR2 deletion. We found that 21% of β-gal + crypts from TgfβR2-mutant mice showed an absence of β-gal + cells characteristic of Paneth cells compared with only 1% of β-gal + crypts in WT mice (P = 0.03; Fig. 4A ). We also analyzed Lgr5-CreER mice and noted that, at 4 wk following TgfβR2 loss, there was an average of 5.9 ± 0.4 β-gal + Paneth cells in WT crypts, but only an average of 3.5 ± 0.4 β-gal + Paneth cells in TgfβR2-mutant crypts (P = 0.002). These results suggest that TgfβR2-mutant ISCs are less likely to generate Paneth cells than WT ISCs.
To study further the effects of TgfβR2 loss on differentiation, we used the TgfβR2 IEKO mice (17, 19) to determine whether the effect of TgfβR2 loss on the formation of Paneth cells was caused by competition with WT cells or by an inherent defect of TgfβR2-mutant crypts. Interestingly, we observed 18% fewer Paneth cells per crypt section in TgfβR2 IEKO mice compared with TgfβR2 fx mice To study further the effects of Tgfβ signaling modifications on the intestinal epithelium, we used cultured mouse proximal small intestinal enteroids, which are self-perpetuating and capable of producing each of the cell types characteristic of the intestinal epithelium (29) . The enteroids allow us to study the early and rapid effects of both up-and down-regulating Tgfβ signaling by treating with either an inhibitor of TgfβR1/2 (30) or Tgfβ1 ligand. Intestinal enteroids treated with high levels of Tgfβ1 ligand (4 ng/mL) results in cell death as seen previously (31) and could be rescued by cotreatment with the inhibitor of TgfβR1/2 (Fig. S6A) . Because initial treatment with 4 ng/mL of Tgfβ1 ligand resulted in rapid enteroid death, we treated enteroids with the highest dose that did not induce enteroid death (0.04 ng/mL Tgfβ1 ligand; Fig. S6A ). Although Tgfβ responsive cells (pSmad2/3 + ) were rare (<3% of all cells) in both untreated and 0.04 ng/mL Tgfβ1-treated enteroids, Tgfβ1 treatment resulted in an approximately ninefold increased fraction of pSmad2/3 + cells compared with untreated (P = 0.003; Fig. S7A ), suggesting this level of Tgfβ1 ligand increases Tgfβ signaling but only in a limited number of cells.
To identify global changes in enteroids after altering Tgfβ signaling, we used Gene Set Enrichment Analysis (GSEA) (32) to determine if our treatment groups had similar gene expression enrichment for stem cell genes by comparing Lgr5-GFP high cells with Lgr5-GFP low cells (33) . GSEA on the microarray data showed that the Tgfβ inhibitor resulted in decreased expression of genes characteristic of stem cells, whereas Tgfβ ligand treatment showed increased expression of the same genes from stem cells (Fig. 5A) . In support of a reduced stem cell signature with Tgfβ inhibition, we observed a reduced rate of crypt bud formation following treatment of enteroids with the TgfβR1/2 inhibitor (Fig. 5B) .
Treatment with either the TgfβR1/2 inhibitor or 0.04 ng/mL Tgfβ1 ligand had no detectable effect of proliferation within the crypt bud (where the ISCs are located), but dramatically decreased proliferation outside of the crypt bud (Fig. S6B) . These results further support the in vivo data that Tgfβ signaling does not affect ISC division rates, but instead support that the effects Tgfβ signaling are on ISC dynamics and clonal expansion.
Cultured Intestinal Enteroids Reveal a Role for Tgfβ Signaling in
Differentiation Toward Secretory Cell Lineage Precursors. To determine whether altered Tgfβ signaling had gene expression enrichment for secretory precursor cell genes, we again started by using GSEA (32) and comparing secretory progenitors with enterocytes (34) . GSEA on the microarray data showed that the Tgfβ inhibitor resulted in decreased expression of genes characteristic of secretory precursor cells, whereas Tgfβ ligand treatment showed increased expression of the same genes (Fig. 5C) . To confirm the expression array data, we stained for the lectin from Ulex europaeus (UEA), which is a marker for the secretory cell lineage: Paneth, enteroendocrine, and Goblet cells (35) . We found that the low dose of Tgfβ1 ligand resulted in an increased number of UEA + cells per bud (equivalent to the crypt), whereas treatment of the enteroids with the TgfβR1/2 inhibitor resulted in a decreased number of UEA + cells per bud (Fig. S7B ). These data in intestinal enteroids support the in vivo data that Tgfβ signaling is key for differentiation toward the secretory cell lineage.
To study further the role of Tgfβ signaling in differentiation toward the secretory lineage, we altered Tgfβ signaling in combination with inhibiting Notch signaling, which is known to be critical for formation of the secretory cell lineage (36) . We pretreated enteroids with either the Tgfβ1 ligand or TgfβR1/2 inhibitor for 2 d and then cotreated with the γ-secretase inhibitor DAPT for 4 d. Enteroids were examined for expression of the secretory cell marker gene, lysozyme, and a control gene, GAPDH, via qRT-PCR. In agreement with the microarray data, lysozyme expression was increased in enteroids treated with Tgfβ1 ligand (1.7-fold) and decreased with Tgfβ inhibition (0.2-fold). As expected, we found that DAPT treatment had a dramatic increase (sevenfold) on lysozyme expression in control enteroids (Fig. 5D) . Interestingly, the combination of Tgfβ1 and DAPT treatment exponentially increased the expression of lysozyme (40-fold) in enteroids compared with control enteroids (Fig. 5D ). These data suggest that Tgfβ signaling is acting on a precursor secretory cell lineage or ISC, which facilitates rapid formation of secretory cells when Notch signaling is inhibited. To determine the relevance of these findings to human intestine, we cultured enteroids from a normal human duodenum. We found that increasing Tgfβ signaling increased GSEA for stem cell genes and secretory precursor cell genes (Fig. S8A ) and increased the rate of new crypt bud formation (Fig. S8B ). With time in culture, human enteroids progress from the budding phenotype to a more cyst-like phenotype. Notch inhibition (DAPT) alone dramatically increased the rate of invagination, which is an initial step in creating buds (Fig. S8C) . Interestingly, the combination of DAPT and Tgfβ1 ligand treatment increased the number of invaginated enteroids compared with the DAPT-treated enteroids (Fig. S8C) , supporting a role for Tgfβ signaling in conjunction with Notch inhibition in differentiation. These data are in agreement with our findings in mice and suggest that Tgfβ signaling is important in regulating stem cell dynamics and differentiation toward a precursor secretory cell lineage in human small intestinal epithelium.
Regeneration After Damage. To study further the effects of altering Tgfβ signaling on crypt regeneration, we treated enteroids with either the Tgfβ inhibitor or ligand and the cytotoxic agent, FUDR (5-fluoro-2′-deoxyuridine), which kills proliferating cells (37) . We pretreated enteroids for 3 d with the TgfβR1/2 inhibitor or Tgfβ1 ligand and then added FUDR for 1 d and allowed the enteroids to recover for 2 d. We found that altering the Tgfβ pathway alone had minimal impact on enteroid survival. However, when treated with FUDR, the TgfβR1/2 inhibitor pretreated enteroids showed decreased survival, whereas survival was increased in the enteroids pretreated with Tgfβ1 ligand (Fig. S9) . These results again support the in vivo data that Tgfβ signaling has a role in crypt regeneration.
Discussion
Multiple mammalian ISCs within each crypt are maintained by a population niche mechanism of ISC clone expansion and extinction, ultimately resulting in neutral drift (8, 9) . These differentially fated ISCs provide flexibility because any ISC clone extinction is readily compensated by neighboring ISC clone expansion. Although neutral drift is normally random, mutations within ISCs can alter clonal dynamics and induce selection as shown previously in ISCs with sporadic Apc or Kras mutations (21, 22) . Here, we demonstrate that ISC clonal dynamics can be modulated genetically by mutations in TgfβR2. Specifically, stochastic loss of TgfβR2 resulted in increased ISC clone survival compared with WT ISCs, but at the cost of clone expansion. In combination with the effects on ISC clonal dynamics, our data in vivo and in cultured enteroids strongly implicate Tgfβ signaling in the transition from ISC to a precursor secretory cell lineage. Thus, when an ISC receives Tgfβ signaling and transitions toward the secretory lineage, the end result for that ISC clone is extinction. Importantly, our data also suggest that Tgfβ signaling and thus precursor secretory cells are important in clone expansion, crypt fission, and ISC regeneration.
Here, we show that TgfβR2 plays an important role in maintenance of the ISC clonal dynamics, which has important implications for cancer, tissue regeneration, and inflammation. First, the increased ISC clone survival comes at the cost of reduced ISC clone expansion and crypt fission, which will hinder tumor initiation and progression. In contrast, stochastic mutations in Apc or Kras increase crypt fission and clonal expansion (21, (23) (24) (25) . Thus, it is likely that the reduced ISC clonal expansion and crypt fission following TgfβR2 mutation represents a key reason why TgfβR2 mutations are rare early mutational events in sporadic CRC (38) . Second, the decreased ISC clone expansion and crypt fission following sporadic TgfβR2 mutations is detrimental to ISC and tissue regeneration following damage lending credence for why Tgfβ signaling is important for recovery after tissue damage (39, 40) . Third, the correlation between Tgfβ signaling and formation of the secretory cell lineage has important implications in intestinal infection and inflammatory diseases. Specifically, Paneth cells maintain the homeostatic balance between the epithelium and the microbiota and are at the site of inflammation (41, 42) . In conclusion, our data reveal the consequences of TgfβR2 loss on ISC clonal dynamics and differentiation with implications for how mutation of TgfβR2 can impact tissue homeostasis and alter tumorigenesis.
Methods
Complete materials and methods are reported in SI Methods and Table S2 . All mouse experiments were approved by the Institutional Animal Care and Use Committee at Oregon Health and Science University. Intestines were stained for β-gal activity as previously described (25) . Human duodenum was obtained with institutional review board approval at OHSU. Enteroids were treated with 20 μM LY2109761 (TgfβR1/2 inhibitor) (Adooq) (30) or 0.04 ng/mL (unless specified differently) Tgfβ1 ligand (R&D Biosystems). The computational model is a continuous-time, asynchronous model with a constant number of stem cells (N), modified from a previous model (22) . To calculate statistical significance, we used univariate linear regressions in StatistiXL on both datasets (WT and mutant) and compared the slopes of each regression with ANOVA.
